Harbin Gloria Pharmaceuticals Co Ltd
SZSE:002437

Watchlist Manager
Harbin Gloria Pharmaceuticals Co Ltd Logo
Harbin Gloria Pharmaceuticals Co Ltd
SZSE:002437
Watchlist
Price: 2.68 CNY Market Closed
Market Cap: 6.1B CNY
Have any thoughts about
Harbin Gloria Pharmaceuticals Co Ltd?
Write Note

Operating Margin
Harbin Gloria Pharmaceuticals Co Ltd

10.6%
Current
5%
Average
6.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
10.6%
=
Operating Profit
257.1m
/
Revenue
2.4B

Operating Margin Across Competitors

Country CN
Market Cap 6.1B CNY
Operating Margin
11%
Country JP
Market Cap 776 550.9T JPY
Operating Margin
-83%
Country US
Market Cap 729.3B USD
Operating Margin
35%
Country UK
Market Cap 440.4B GBP
Operating Margin
3%
Country DK
Market Cap 2.6T DKK
Operating Margin
44%
Country US
Market Cap 347.8B USD
Operating Margin
28%
Country US
Market Cap 248.3B USD
Operating Margin
34%
Country CH
Market Cap 197.2B CHF
Operating Margin
32%
Country UK
Market Cap 159B GBP
Operating Margin
21%
Country CH
Market Cap 169.7B CHF
Operating Margin
31%
Country US
Market Cap 149.4B USD
Operating Margin
22%
No Stocks Found

Harbin Gloria Pharmaceuticals Co Ltd
Glance View

Market Cap
6.1B CNY
Industry
Pharmaceuticals

Harbin Gloria Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of medicines. The company is headquartered in Beijing, Beijing and currently employs 4,769 full-time employees. The company went IPO on 2010-06-23. The firm's products include cardiovascular and cerebrovascular drugs, orthopedic drugs, nutritional drugs, anti-infective drugs, immune-enhancing drugs, diabetes drugs, antineoplastic drugs and electrolytes drugs. The firm is also engaged in the agency, research and development of pharmaceuticals, the provision of clinical services and financial investment business. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
2.32 CNY
Overvaluation 14%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
10.6%
=
Operating Profit
257.1m
/
Revenue
2.4B
What is the Operating Margin of Harbin Gloria Pharmaceuticals Co Ltd?

Based on Harbin Gloria Pharmaceuticals Co Ltd's most recent financial statements, the company has Operating Margin of 10.6%.